LDFR
CLVS

Lehman & Derafelo Financial Resources’s Clovis Oncology, Inc. CLVS Stock Holding History

Lehman & Derafelo Financial Resources’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,000
Closed -$23K – 282
2020
Q3 		$23K Buy
+4,000
New +$23.9K 0.01% 198

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lehman & Derafelo Financial Resources's CLVS Position: Q4 2020 in Review

Lehman & Derafelo Financial Resources sold out of Clovis Oncology, Inc. (CLVS) in Q4 2020, closing a stake of 4,000 shares — an estimated $23K sold.

Lehman & Derafelo Financial Resources first reported a position in CLVS in Q3 2020 and held it in 1 quarter. The position peaked at $23K in Q3 2020. 159 funds tracked by Wall St. Rank hold CLVS as of Q4 2020.

  • Lehman & Derafelo Financial Resources reported no remaining Clovis Oncology, Inc. position as of Q4 2020 after selling out during the quarter.
  • Lehman & Derafelo Financial Resources sold 4,000 Clovis Oncology, Inc. shares in Q4 2020, an estimated $23K.
  • Lehman & Derafelo Financial Resources first reported a position in Clovis Oncology, Inc. in Q3 2020 and held it in 1 quarter.
  • Lehman & Derafelo Financial Resources's Clovis Oncology, Inc. position peaked at $23K in Q3 2020.
  • 159 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2020.

Based on Lehman & Derafelo Financial Resources's 13F filing for Q4 2020, filed 20 Jan 2021.